Physician profile
Veronica Garrett
NPI 1447224324
$2,735.20
in general payments reported to CMS, 2019-2025
25 companies · $486 in 2025
The $486 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $225 · 2021: $261 · 2022: $580 · 2023: $455 · 2024: $303 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239 · Education: $4.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.20 |
| Education | $4.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $707.10 | 2019-2023 | |
| Astellas Pharma US INC | $537.74 | 2022-2025 | Veozah |
| Organon LLC | $192.36 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $189.26 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $184.38 | 2019-2025 | |
| Minerva Surgical, INC | $136.22 | 2022-2025 | |
| Myovant Sciences INC. | $108.32 | 2021-2022 | |
| Intuitive Surgical, INC. | $100.09 | 2022-2024 | |
| Medtronic, INC. | $89.52 | 2023 | Truclear |
| Aspira Women'S Health INC | $64.37 | 2021 | |
| Channel Medsystems, INC. | $62.95 | 2025 | |
| Coopersurgical, INC. | $49.28 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $46.65 | 2022-2023 | |
| Ethicon US, LLC | $38.01 | 2020-2022 | |
| Hologic Sales and Service, LLC | $37.98 | 2019-2025 | Aptima |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $35.83 | 2021-2022 | |
| Roche Diagnostics Corporation | $28.90 | 2019-2020 | |
| Evofem Biosciences, INC. | $20.83 | 2023 | Phexxi |
| Teva Pharmaceuticals USA, INC. | $18.35 | 2019 | |
| Meditrina | $17.92 | 2022-2023 | |
| Allergan, INC. | $16.51 | 2019 | |
| Scynexis, INC. | $15.73 | 2022 | |
| Davol INC. | $12.87 | 2021 | |
| Exeltis, USA INC. | $12.29 | 2020 | |
| Avion Pharmaceuticals | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.